Recent Activity

Loading...

ELAN

Elanco Animal Health, Inc. · NYSE

Performance

+28.34%

1W

+8.55%

1M

+7.03%

3M

+57.85%

6M

+13.36%

YTD

+80.45%

1Y

Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield, Indiana.

Investment Analysis Report: ELAN

Overview

ELAN is a company operating in the Health Technology sector, specifically in the Biotechnology industry. With a market capitalization of $8.08 billion, ELAN has been a significant player in the industry. In this report, we will conduct a comprehensive analysis of ELAN's financial statements over the past...

See more ...

Technical Analysis of ELAN 2024-05-03

Overview:

In analyzing the technical indicators for ELAN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates